Tower Research Capital (TRC)’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,338
| Closed | -$3.44K | – | 5873 |
|
|
2024
Q3 | $3.44K | Sell |
1,338
-17,572
| -93% | -$45.2K | ﹤0.01% | 4846 |
|
|
2024
Q2 | $37.1K | Buy |
18,910
+12,343
| +188% | +$24.2K | ﹤0.01% | 3325 |
|
|
2024
Q1 | $17.5K | Buy |
6,567
+3,489
| +113% | +$9.28K | ﹤0.01% | 3121 |
|
|
2023
Q4 | $12.8K | Buy |
3,078
+412
| +15% | +$1.71K | ﹤0.01% | 4019 |
|
|
2023
Q3 | $3.68K | Sell |
2,666
-3,937
| -60% | -$5.43K | ﹤0.01% | 4973 |
|
|
2023
Q2 | $20.7K | Buy |
6,603
+6,395
| +3,075% | +$20K | ﹤0.01% | 3328 |
|
|
2023
Q1 | $1K | Sell |
208
-1,493
| -88% | -$7.18K | ﹤0.01% | 5572 |
|
|
2022
Q4 | $8K | Buy |
1,701
+870
| +105% | +$4.09K | ﹤0.01% | 4420 |
|
|
2022
Q3 | $7K | Buy |
831
+418
| +101% | +$3.52K | ﹤0.01% | 4899 |
|
|
2022
Q2 | $5K | Buy |
413
+101
| +32% | +$1.22K | ﹤0.01% | 5072 |
|
|
2022
Q1 | $5K | Buy |
312
+306
| +5,100% | +$4.9K | ﹤0.01% | 5067 |
|
|
2021
Q4 | $0 | Sell |
6
-7,628
| -100% | – | ﹤0.01% | 6372 |
|
|
2021
Q3 | $307K | Buy |
7,634
+7,510
| +6,056% | +$302K | 0.01% | 1379 |
|
|
2021
Q2 | $2K | Sell |
124
-1,009
| -89% | -$16.3K | ﹤0.01% | 5054 |
|
|
2021
Q1 | $22K | Buy |
+1,133
| New | +$22K | ﹤0.01% | 3812 |
|
|
2020
Q4 | – | Sell |
-320
| Closed | -$6K | – | 5294 |
|
|
2020
Q3 | $6K | Sell |
320
-3,123
| -91% | -$58.6K | ﹤0.01% | 4295 |
|
|
2020
Q2 | $72K | Buy |
+3,443
| New | +$72K | ﹤0.01% | 2751 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$8K | – | 4126 |
|
|
2018
Q3 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 2890 |
|